Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411

Cyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detect...

Full description

Bibliographic Details
Main Authors: Hanna Mazur-Marzec, Anna Fidor, Marta Cegłowska, Ewa Wieczerzak, Magdalena Kropidłowska, Marie Goua, Jenny Macaskill, Christine Edwards
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/16/7/220
_version_ 1811184752962568192
author Hanna Mazur-Marzec
Anna Fidor
Marta Cegłowska
Ewa Wieczerzak
Magdalena Kropidłowska
Marie Goua
Jenny Macaskill
Christine Edwards
author_facet Hanna Mazur-Marzec
Anna Fidor
Marta Cegłowska
Ewa Wieczerzak
Magdalena Kropidłowska
Marie Goua
Jenny Macaskill
Christine Edwards
author_sort Hanna Mazur-Marzec
collection DOAJ
description Cyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detected in the cyanobacterium Nostoc edaphicum CCNP1411 isolated from the Gulf of Gdańsk (southern Baltic Sea). Structural elucidation was performed by tandem mass spectrometry with verification by NMR for CP962 and CP985. Trypsin and chymotrypsin inhibition assays confirmed the significance of the residue adjacent to 3-amino-6-hydroxy-2-piperidone (Ahp) for the activity of the peptides. Arginine-containing CPs (CPs-Arg2) inhibited trypsin at low IC50 values (0.24–0.26 µM) and showed mild activity against chymotrypsin (IC50 3.1–3.8 µM), while tyrosine-containing CPs (CPs-Tyr2) were selectively and potently active against chymotrypsin (IC50 0.26 µM). No degradation of the peptides was observed during the enzyme assays. Neither of the CPs were active against thrombin, elastase or protein phosphatase 1. Two CPs (CP962 and CP985) had no cytotoxic effects on MCF-7 breast cancer cells. Strong and selective activity of the new cyanopeptolin variants makes them potential candidates for the development of drugs against metabolic disorders and other diseases.
first_indexed 2024-04-11T13:18:48Z
format Article
id doaj.art-15e70a6c7481452896d1716ee0c20b0f
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T13:18:48Z
publishDate 2018-06-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-15e70a6c7481452896d1716ee0c20b0f2022-12-22T04:22:18ZengMDPI AGMarine Drugs1660-33972018-06-0116722010.3390/md16070220md16070220Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411Hanna Mazur-Marzec0Anna Fidor1Marta Cegłowska2Ewa Wieczerzak3Magdalena Kropidłowska4Marie Goua5Jenny Macaskill6Christine Edwards7Division of Marine Biotechnology, Faculty of Oceanography and Geography, University of Gdańsk, Marszałka J. Piłsudskiego 46, PL-81378 Gdynia, PolandDivision of Marine Biotechnology, Faculty of Oceanography and Geography, University of Gdańsk, Marszałka J. Piłsudskiego 46, PL-81378 Gdynia, PolandInstitute of Oceanology, Polish Academy of Sciences, Powstańców Warszawy 55, PL-81712 Sopot, PolandDepartment of Biomedical Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, PL-80308 Gdańsk, PolandDepartment of Biomedical Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, PL-80308 Gdańsk, PolandSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen AB10 7GJ, UKSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen AB10 7GJ, UKSchool of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen AB10 7GJ, UKCyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detected in the cyanobacterium Nostoc edaphicum CCNP1411 isolated from the Gulf of Gdańsk (southern Baltic Sea). Structural elucidation was performed by tandem mass spectrometry with verification by NMR for CP962 and CP985. Trypsin and chymotrypsin inhibition assays confirmed the significance of the residue adjacent to 3-amino-6-hydroxy-2-piperidone (Ahp) for the activity of the peptides. Arginine-containing CPs (CPs-Arg2) inhibited trypsin at low IC50 values (0.24–0.26 µM) and showed mild activity against chymotrypsin (IC50 3.1–3.8 µM), while tyrosine-containing CPs (CPs-Tyr2) were selectively and potently active against chymotrypsin (IC50 0.26 µM). No degradation of the peptides was observed during the enzyme assays. Neither of the CPs were active against thrombin, elastase or protein phosphatase 1. Two CPs (CP962 and CP985) had no cytotoxic effects on MCF-7 breast cancer cells. Strong and selective activity of the new cyanopeptolin variants makes them potential candidates for the development of drugs against metabolic disorders and other diseases.http://www.mdpi.com/1660-3397/16/7/220cyanobacteriaNostoccyanopeptolinsprotease inhibitors
spellingShingle Hanna Mazur-Marzec
Anna Fidor
Marta Cegłowska
Ewa Wieczerzak
Magdalena Kropidłowska
Marie Goua
Jenny Macaskill
Christine Edwards
Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
Marine Drugs
cyanobacteria
Nostoc
cyanopeptolins
protease inhibitors
title Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
title_full Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
title_fullStr Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
title_full_unstemmed Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
title_short Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411
title_sort cyanopeptolins with trypsin and chymotrypsin inhibitory activity from the cyanobacterium nostoc edaphicum ccnp1411
topic cyanobacteria
Nostoc
cyanopeptolins
protease inhibitors
url http://www.mdpi.com/1660-3397/16/7/220
work_keys_str_mv AT hannamazurmarzec cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT annafidor cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT martacegłowska cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT ewawieczerzak cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT magdalenakropidłowska cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT mariegoua cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT jennymacaskill cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411
AT christineedwards cyanopeptolinswithtrypsinandchymotrypsininhibitoryactivityfromthecyanobacteriumnostocedaphicumccnp1411